Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids and neuropathic pain.

P Goya1, N Jagerovic, L Hernandez-Folgado

  • 1Instituto de Química Médica, CSIC, c/Juan de la Cierva 3, E-28006, Madrid, Spain. iqmg310@iqm.csic.es

Mini Reviews in Medicinal Chemistry
|October 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic pain.

Neuropharmacology·2026
Same author

Key components of effective non-pharmacological interventions for childhood obesity: a review considering social determinants of health.

European journal of pediatrics·2025
Same author

Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB<sub>2</sub> receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].

Pharmacological research·2017
Same author

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.

Pharmacological research·2016
Same author

Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation.

Journal of medicinal chemistry·2015
Same author

Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat.

Neurogastroenterology and motility·2013

Cannabinoids show promise for managing neuropathic pain by interacting with the endocannabinoid system. This review details key findings on cannabinoids and their effects on nerve pain.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • The endocannabinoid system involves CB receptors and endocannabinoids.
  • Cannabinergic ligands are compounds that interact with this system.

Purpose of the Study:

  • To provide an overview of the endocannabinoid system and related ligands.
  • To discuss general aspects of cannabinoids and pain.
  • To detail findings on cannabinoids and neuropathic pain.

Main Methods:

  • Literature review and synthesis of existing research.
  • Discussion of general principles of cannabinoid pharmacology.
  • Detailed analysis of studies on neuropathic pain.

Main Results:

  • Cannabinoids interact with the endocannabinoid system to modulate pain signaling.

Related Experiment Videos

  • Evidence suggests therapeutic potential for cannabinoids in neuropathic pain conditions.
  • Specific findings on the efficacy and mechanisms are discussed.

    • Conclusions:

    • Cannabinoids represent a potential therapeutic avenue for neuropathic pain.
    • Further research is warranted to fully elucidate their role and optimize treatments.
    • Understanding the endocannabinoid system is crucial for developing cannabinoid-based therapies.